XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statement - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Feb. 03, 2018   81,371,118       60,252,569  
Beginning balance at Feb. 03, 2018 $ 933,475 $ 813 $ 498,249 $ 1,132,173 $ (93,062) $ (621,354) $ 16,656
Cumulative adjustment from adoption of new accounting guidance at Feb. 03, 2018 5,829     5,829      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (20,987)     (21,221)     234
Foreign currency translation adjustment (24,572)       (24,248)   (324)
Gain on derivative financial instruments designated as cash flow hedges 8,084       8,084    
Actuarial valuation and prior service credit amortization and foreign currency and other adjustments on defined benefit plans 436       436    
Issuance of common stock under stock compensation plans including tax effect (in shares)   689,341          
Issuance of common stock under stock compensation plans including tax effect 3,890 $ 8 3,882        
Issuance of stock under Employee Stock Purchase Plan (in shares)   15,313       (15,313)  
Issuance of stock under Employee Stock Purchase Plan 230   71     $ 159  
Share-based compensation 3,958   3,949 9      
Dividends (18,499)     (18,499)      
Share repurchases (in shares)   (1,118,808)       1,118,808  
Share repurchases (17,587) $ (11) 11     $ (17,587)  
Ending balance (in shares) at May. 05, 2018   80,956,964.000       61,356,064  
Ending balance at May. 05, 2018 $ 874,257 $ 810 506,162 1,098,291 (108,790) $ (638,782) 16,566
Beginning balance (in shares) at Feb. 02, 2019 81,379,660 81,379,660       61,327,640  
Beginning balance at Feb. 02, 2019 $ 853,645 $ 814 523,331 1,077,747 (126,179) $ (638,486) 16,418
Cumulative adjustment from adoption of new accounting guidance at Feb. 02, 2019 297     (1,684) 1,981    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (20,581)     (21,374)     793
Foreign currency translation adjustment (12,067)       (12,377)   310
Gain on derivative financial instruments designated as cash flow hedges 3,683       3,683    
Actuarial valuation and prior service credit amortization and foreign currency and other adjustments on defined benefit plans 186       186    
Issuance of common stock under stock compensation plans including tax effect (in shares)   545,881       (211,221)  
Issuance of common stock under stock compensation plans including tax effect (812) $ 5 (3,042)     $ 2,225  
Issuance of stock under Employee Stock Purchase Plan (in shares)   11,377       (11,377)  
Issuance of stock under Employee Stock Purchase Plan 190 $ 1 69     $ 120  
Share-based compensation 4,468   4,440 28      
Dividends (18,331)     (18,331)      
Share repurchases (in shares)   (10,264,052)       10,264,052  
Share repurchases (201,564) $ (103) 103     $ (201,564)  
Equity component value of convertible note issuance, net 42,324   42,324        
Sale of common stock warrant 28,080   28,080        
Purchase of convertible note hedge (46,440)   (46,440)        
Equity forward contract issuance $ (68,000)   (68,000)        
Ending balance (in shares) at May. 04, 2019 71,672,866 71,672,866       71,369,094  
Ending balance at May. 04, 2019 $ 565,078 $ 717 $ 480,865 $ 1,036,386 $ (132,706) $ (837,705) $ 17,521